Filing Details
- Accession Number:
- 0000950170-24-042681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-08 17:09:38
- Reporting Period:
- 2024-04-04
- Accepted Time:
- 2024-04-08 17:09:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746298 | Scott Richard Struthers | C/O Crinetics Pharmaceuticals, Inc. 6055 Lusk Boulevard San Diego CA 92121 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-04 | 40,951 | $9.28 | 278,786 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-04 | 40,951 | $49.17 | 237,835 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified stock option (Right to Buy) | Disposition | 2024-04-04 | 40,951 | $0.00 | 40,951 | $9.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 123,790 | 2028-05-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 570,805 | Indirect | By Family Trust 1 |
| Common Stock | 110,000 | Indirect | By Family Trust 2 |
| Common Stock | 110,000 | Indirect | By Family Trust 3 |
| Common Stock | 110,000 | Indirect | By Family Trust 4 |
| Common Stock | 1,000 | Indirect | By Spouse |
Footnotes
- The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan.
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $49.17 per share. The range of sales prices on the transaction date was $48.95 to $49.56 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- 1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Billionaire Hedge Funds
